sorafenib has been researched along with 4-hydroxy-2-nonenal in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (4-hydroxy-2-nonenal) | Trials (4-hydroxy-2-nonenal) | Recent Studies (post-2010) (4-hydroxy-2-nonenal) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 3,034 | 26 | 1,103 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Chen, C; Chen, Y; Gao, Q; Hu, Y; Huang, A; Lei, C; Liang, L; Tang, H; Tang, N; Wang, K; Xia, J; Yang, Y; Zhang, G; Zhang, W; Zheng, Y | 1 |
1 other study(ies) available for sorafenib and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
Topics: Aldehydes; Amino Acid Sequence; Animals; Antioxidants; Apoptosis; Base Sequence; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Fatty Acid Transport Proteins; Fatty Acids, Unsaturated; Female; Gene Expression Regulation, Neoplastic; Humans; Kelch-Like ECH-Associated Protein 1; Lipid Peroxidation; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Sorafenib; Thioredoxin Reductase 1 | 2020 |